Not Out of Largesse: Big Pharma's (Very Addictive) Wonder Drug

Abby Zimet

With the patent on OxyContin due to expire soon and almost $3 billion in sales at stake, Motherboard looks at the insidious ways that Purdue Pharma got America hooked, from its touting of time-release effects and controversial trials for kids to a PR blitz encompassing speaker-training conferences, all-expenses-paid symposia, starter coupons, public endorsements, a website full of spin and much dubious advertising in the form of a “public service” program that sang its praises. Worst, the company once dismissed the risks of an addiction that is now known to "bring addicts to their knees," and which has seen the death rate from opioids overdoses triple in just 15 years to now surpass the combined overdose deaths of cocaine and heroin. Today, it's increasingly said Purdue had to know "what the deal was."

FRIENDS: Now More Than Ever

Independent journalism has become the last firewall against government and corporate lies. Yet, with frightening regularity, independent media sources are losing funding, closing down or being blacked out by Google and Facebook. Never before has independent media been more endangered. If you believe in Common Dreams, if you believe in people-powered independent media, please support us now and help us fight—with truths—against the lies that would smother our democracy. Please help keep Common Dreams alive and growing. Thank you. -- Craig Brown, Co-founder

Support Common DreamsSupport Common Dreams

Share This Article

More in: